Search
Pfizer Inc
PFEAdd to Watchlist
25.210USD
-0.700-2.70%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
143.67BMarket Cap
19.15P/E TTM
Revenue Breakdown
Currency: USDUpdated: Mon, Apr 6
Currency: USDUpdated: Mon, Apr 6
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
By BusinessUSD
Name
Revenue
Proportion
Eliquis alliance revenues and direct sales
7.96B
12.72%
Prevnar family
6.49B
10.38%
Vyndaqel family
6.38B
10.20%
Comirnaty
4.37B
6.98%
Oncology-Ibrance
4.12B
6.59%
Other
33.26B
53.14%
By RegionUSD
Name
Revenue
Proportion
United States
37.08B
59.25%
Developed Markets
16.19B
25.87%
Emerging Markets
9.31B
14.88%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Eliquis alliance revenues and direct sales
7.96B
12.72%
Prevnar family
6.49B
10.38%
Vyndaqel family
6.38B
10.20%
Comirnaty
4.37B
6.98%
Oncology-Ibrance
4.12B
6.59%
Other
33.26B
53.14%
